Tag Archives: Australia

Australia to Permit Medicinal Cannabis Exports in Bid to Capture Lucrative Market

Australia to Permit Medicinal Cannabis Exports in Bid to Capture Market

Australia said on Thursday it planned to become the fourth country in the world to legalise medicinal marijuana exports in a bid to score a piece of the estimated $55 billion global market.

Zelda Announces Priority Share Offer for CannPal Animal Therapeutics IPO Shares

Zelda Joins with US Children’s Hospital to Study Cannabinoid Treatment in Autism

PERTH, Australia, Dec. 11, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it has entered into a research agreement with Children’s Hospital of Philadelphia (CHOP) to study the pharmacology of cannabinoids.

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

Final Operational Licence Now in Place

CARABOODA, Western Australia, Dec. 7, 2017 /Weed Wire/ – The licence was granted under the Narcotic Drugs Act 1967 to Tasmanian Alkaloids, AusCann’s strategic partner and allows for the joint manufacture and supply of medical cannabis products in Australia.

Canada’s Aurora Cannabis Boosts Stake in Australia-Based Cann Group

Canada’s Aurora Cannabis Boosts Stake in Australia-Based Cann Group

Canada’s Aurora Cannabis Inc (ACB.TO) said on Monday it increased its stake in Australia-based Cann Group Ltd (CAN.AX) to 22.9 percent from 19.9 percent, its latest move to expand in the cannabis industry.

THC

Major Israeli Medicinal Cannabis company BOL Pharma partners with THC in Australia

SYDNEY, Australia, Nov. 20, 2017 /Weed Wire/ — The Hydroponics Company Limited (ASX:THC) (“THC”) is pleased to announce that its wholly owned subsidiary Canndeo Limited has entered into a Letter of Intent (LOI) with leading Israeli medicinal cannabis group BOL Pharma Limited (BOL) for the supply of cannabinoid related products in Australia.

THC

THC Signs Medicinal Cannabis Distribution Agreement with Major European Distributor, Endoca

SYDNEY, Australia, Nov. 15, 2017 /Weed Wire/ — The Hydroponics Company Limited (ASX:THC) (“THC” or “the Company”) is pleased to announce that its wholly-owned subsidiary Canndeo Limited has signed a distribution agreement with Endoca, a European provider of high quality pharmaceutical grade medicinal cannabis, to distribute medicinal cannabis products into Australia.

Corix Biosciences

Corix Bioscience Purchases Pharmaceutical Development Corp LTD

PHOENIX, Ariz., Nov. 7, 2017 /Weed Wire/ — Corix Bioscience Inc. (OTCQB: CXBS) has purchased 100% of Pharmaceutical Development Corp., allowing Corix to commence selling its proprietary cannabis products internationally.

Unlikely Allies Eye Vote to Legalize Cannabis in New Zealand

Unlikely Allies Eye Vote to Legalize Cannabis in New Zealand

New Zealand could become the first country in the Asia-Pacific region to legalize cannabis for personal use after an unlikely alliance of populist, centrist and leftist parties put drug policy immediately on the agenda of the incoming government.

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

AusCann: Medical Liason Managers Appointed

CARABOODA, Western Australia, Sept. 14, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce it has appointed three Medical Liaison Managers (MLMs), to manage doctor communications and assist in the prescription of AusCann’s cannabinoid medicines in Australia.

Olivia Newton-John Reveals She Used Marijuana to Ease Cancer Pains

Olivia Newton-John Reveals She Used Marijuana to Ease Cancer Pains

Olivia Newton-John opens up about her second bout with cancer in a new interview with Australia’s “60 Minutes,” saying that at one point she couldn’t walk. The singer even admits that she used medical marijuana as treatment to ease the pain.

THC

Sinapse Partnership to Facilitate Prescribing and Dispensing of Medicinal Cannabis in Australia

SYDNEY, Australia, Sept. 1, 2017 /Weed Wire/ – The Hydroponics Company Limited (ASX: THC) is pleased to announce the first partnership with Sinapse Pty Ltd (Sinapse) as a key partner in its strategy to facilitate medicinal cannabis prescribing and dispensing in Australia.

Zelda Announces Priority Share Offer for CannPal Animal Therapeutics IPO Shares

Zelda Announces Priority Share Offer for CannPal Animal Therapeutics IPO Shares

The Board of Zelda Therapeutics Ltd is pleased to announce that its shareholders are invited to participate as a priority applicant in the prospectus capital raising of CannPal Animal Therapeutics Limited (CannPal) lodged with the ASIC.

Zelda Therapeutics Research Programme Zelda autism Research Collaboration

Zelda Expands Its Breast Cancer Research Collaboration with Complutense University Madrid

PERTH, Australia, July 31, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it has expanded its research collaboration with Complutense University.

Australia Cautiously Enters Medical Marijuana Market

Australia Cautiously Enters Medical Marijuana Market

At a secret location in Australia’s southeast, Peter Crock delicately tends to a two-month-old cannabis cutting. Barely knee high, it is one of about 50 government-sanctioned “mother plants” to be cloned for future generations of crops for the country’s fledgling medicinal marijuana industry.

Victoria education

Education Opportunities Open For Medicinal Cannabis

SYDNEY, May 30, 2017 /Weed Wire/ — Victorian tertiary students will now be able to study the supply chain of medicinal cannabis, following the launch of Australia’s first ever full-scale cannabis education program.

THC

ASX Medicinal Cannabis Company Signs Exclusive Strategic Alliance with US-Based Pharmaceutical Company

SYDNEY, Australia, May 24, 2017 /Weed Wire/ — The Hydroponics Company Limited (ASX:THC) (“THC” or “the Company”) is pleased to announce that it has signed an exclusive Strategic Alliance with Colorado-based healthcare solutions company Phoenix Life Sciences Inc (“Phoenix Life”) to collaboratively research, develop, manufacture, distribute and sell medicinal cannabis products in Australia and internationally.

THC

THC:ASX Announcement: 1st Quarter Revenue up 22% And US Expansion

SYDNEY, Australia, May 9, 2017 /Weed Wire/ – The Hydroponics Company Limited (ASX: THC) is pleased to announce that first quarter revenue in its wholly owned subsidiary CMDV (Crystal Mountain (Canada)/Dragon Vision (Hong Kong)) increased by more than 22% year-on-year to over $1.11m.

THC

ASX:THC Commences Trading on the Australian Securities Exchange

SYDNEY, Australia, May 4, 2017 /Weed Wire/ — The Hydroponics Company Limited (ASX:THC or ‘the Company’) is pleased to announce that it has today commenced trading on the Australian Securities Exchange (ASX), following its successful $8m capital raising. The Company is well placed to achieve a number of milestones in the next 6-12 months.

AusCann

AusCann Group Provides Quarterly Overview

CARABOODA, Western Australia, April 28, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) has today announced its appendix 4C for the 3 month period ended 31 March 2017 and is pleased to provide an overview of its activities for the quarter.

Australian Company Harvesting Medical Cannabis Crop in Chile

Australian Company Harvesting Medical Cannabis Crop in Chile

On April 10, 2017, AusCann Group Holdings Ltd (ASX:AC8) announced that it had started harvesting its first medical cannabis crop in Chile through DayaCann, a joint venture between AusCann and the Daya Foundation, a non-profit based in Chile that advocates for alternative therapies.

Aurora Cannabis operational update

Aurora Cannabis to be Cornerstone Investor in Australian Medical Cannabis IPO

VANCOUVER, March 28, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that it has committed to taking part in the initial public offering (“IPO”) of Cann Group Limited (“Cann Group”) on the Australian Stock Exchange (“ASX”) as the cornerstone investor.

Australia-Coat-of-Arms

The Office of Drug Control Grants First Commercial Medicinal Cannabis Licence

CANBERRA, Australia, March 8, 2017 /Weed Wire/ — Today the Office of Drug control issued the second licence under the medicinal cannabis provisions of the Narcotic Drugs Act 1967. This is the first commercial medicinal cannabis licence and authorises the cultivation and production of Australian grown cannabis into the manufacture chain and for subsequent therapeutic supply to Australian patients.

Why these pot stocks smoked the ASX today

Why These Pot Stocks Smoked the ASX Today

It certainly has been a great day for pot stocks on the ASX. This morning Federal Health Minister Greg Hunt announced that the government would allow medical marijuana companies to distribute cannabis oils and medications in Australia within the next couple of months.

Australia-Coat-of-Arms

Office of Drug Control Grants First Cannabis Licence

CANBERRA, Australia, Feb. 20, 2017 /Weed Wire/ — On Friday 17 February 2017, the Office of Drug control issued the very first licence under the medicinal cannabis provisions of the Narcotic Drugs Act 1967. The licence is a cannabis research licence and has been issued to Cannoperations Pty Ltd, a wholly owned subsidiary of the Australian company Cann Group Limited.

Cannabis in Australia: The Case Against Enthusiasm

Cannabis in Australia: The Case Against Enthusiasm

Gaelan Bloomfield and Ram Venkay, partners in a new investment fund that will be managed from Australia and will focus on Calif.-based cannabis investment opportunities, are notably wary about the prospects at home, Down Under.


Page 1 of 212
Top